Cholesterol lowering and mortality: the importance of considering initial level of risk
about
Reduction in saturated fat intake for cardiovascular diseaseReduced or modified dietary fat for preventing cardiovascular diseaseMultiple risk factor interventions for primary prevention of coronary heart diseaseReduced or modified dietary fat for preventing cardiovascular diseaseMultiple risk factor interventions for primary prevention of coronary heart diseaseIssues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomesDietary fat intake and prevention of cardiovascular disease: systematic reviewReduced or modified dietary fat for prevention of cardiovascular disease.Statins and secondary prevention of coronary heart disease.Achieving health gain through clinical guidelines. I: Developing scientifically valid guidelines.Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit.Systematic reviews and meta-analysis: a structured review of the methodological literature.Threats to applicability of randomised trials: exclusions and selective participation.Cholesterol screening and cholesterol lowering treatmentMethods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies.Screening for coronary heart disease risk factors in retail pharmacies in Sheffield, 1992.Role of an Ethanolic Extract of Crotalaria juncea L. on High-Fat Diet-Induced Hypercholesterolemia.Getting research findings into practice. When to act on the evidence.Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance, markers for coronary heart disease.Modelling the effect of baseline risk in meta-analysis: a review from the perspective of errors-in-variables regression.The importance of diet and physical activity in the treatment of conditions managed in general practice.Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trialsEffect of Erythrina variegata seed extract on hyperlipidemia elicited by high-fat diet in wistar ratsApplying the results of clinical trials to patients to general practice: perceived problems, strengths, assumptions, and challenges for the future.Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.High-oleic and high-stearic cottonseed oils: nutritionally improved cooking oils developed using gene silencing.Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits.Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.General practice workload implications of the national service framework for coronary heart disease: cross sectional survey.A flow diagram to facilitate selection of interventions and research for health care.Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?Cholesterol and coronary heart disease: screening and treatment.Expanding access to coronary artery bypass surgery: who stands to gain?Assessing possible hazards of reducing serum cholesterolStatistical problemsImplementing findings of research.Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration.
P2860
Q24187203-90FD2FDB-96C5-427B-A17C-74AEE2ED62DDQ24197817-BC9C03A1-F4AF-4648-A503-A2A3D3A01A1DQ24234642-0922681B-7E7D-42C7-A832-84E629483497Q24235559-CB4C3DAA-C2BD-42AA-897C-9BDCFC6AE48FQ24243941-5F56541D-DA75-4E6B-B12A-D30392314F6DQ28193390-2AD7F520-BC09-4A6C-B34E-4AA3A419A257Q28361678-C6D2425D-02D2-41E4-A9E8-175E2CDE4930Q30868359-55C3D171-CB95-435C-8672-CEBC7F6F8982Q33203028-CE0876A1-89D8-4F68-A790-57D0D5EE41FFQ33553941-6604CBF3-B575-4A7F-BE1A-17A274D285FBQ33614361-4226307F-0EC0-43D8-BAF7-17F2C3241F62Q33645850-4A107AEB-C538-493A-B1C2-9BE5C48095FBQ33674575-C1F3ACA8-9756-429A-B3B6-687BD9FA9F53Q33691286-961420E3-3BC6-4DE7-A338-8227C639E5FBQ33699720-5DCCA1A4-1B65-4B11-9DAF-D23B43B55D72Q33702346-2D76BCA5-AAB1-4668-982A-6D002103FA71Q33784430-BAC410A1-8C53-4155-9C53-2E39ED8E78A7Q33790985-BBAAD3FB-5442-4FF6-8364-AC68FD21826AQ33809391-B4E87577-C22F-444E-BCC7-E06AAFFAABDBQ34015951-20FF6C01-4B59-409C-B03B-E65B93C57FC7Q34054689-76E9E14F-7F35-4ED5-8D71-A882448F6151Q34065021-182AE3E6-09F8-43EA-93C7-FFD23198B438Q34373858-DB6FE774-45ED-4F2D-88F4-61CD092CC3E9Q34469512-15290E79-B2AF-48A8-9A9B-DFAE754A75EBQ34620386-14FD3C18-2351-47AC-981C-641E7E2CF33BQ34692450-ED342D46-3D4C-4A9E-A8C8-9F4E3CBDD6DFQ34711960-F00538E3-5B16-4126-98C8-E4C2C996C868Q35576134-EE7E23EA-7233-4DCA-87A4-E82BDD7596D8Q35639538-8DBCE301-E967-49DB-AD79-DF689C89ECC2Q35803596-E68FDD91-DBDB-44D6-A078-A0796119B2A7Q35808362-B1A7F536-D0B6-4FDD-B43C-A948A4820CD7Q36502029-2DF35008-8418-4DE9-B014-BA15AB43F995Q36551592-568A9EFF-505C-47A6-A101-2A62BAB4671BQ36707882-336F0AC0-612E-4AFE-A440-189797EF58CBQ36790859-740ECA59-1C24-4EB8-90E2-808EB87D7C3EQ36816083-3AF6A5FD-5EF3-4155-9670-E88C17132FA9Q36884291-2B923DB9-7C68-4EAD-ABA5-9AB2D86D13FCQ36885016-17A53551-4D5C-414C-B151-143FDAEE2A9CQ36885755-22C95974-99CD-48F4-B4AB-9B495EB84BABQ36887008-E4D8CC55-F42C-45C8-8FB8-6E758D37ED73
P2860
Cholesterol lowering and mortality: the importance of considering initial level of risk
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Cholesterol lowering and mortality: the importance of considering initial level of risk
@ast
Cholesterol lowering and mortality: the importance of considering initial level of risk
@en
Cholesterol lowering and mortality: the importance of considering initial level of risk
@nl
type
label
Cholesterol lowering and mortality: the importance of considering initial level of risk
@ast
Cholesterol lowering and mortality: the importance of considering initial level of risk
@en
Cholesterol lowering and mortality: the importance of considering initial level of risk
@nl
prefLabel
Cholesterol lowering and mortality: the importance of considering initial level of risk
@ast
Cholesterol lowering and mortality: the importance of considering initial level of risk
@en
Cholesterol lowering and mortality: the importance of considering initial level of risk
@nl
P2093
P2860
P1433
P1476
Cholesterol lowering and mortality: the importance of considering initial level of risk
@en
P2093
P2860
P304
P356
10.1136/BMJ.306.6889.1367
P407
P577
1993-05-22T00:00:00Z